Genomic analysis and differential expression of HMG and S100A family in human arthritis: Upregulated expression of chemokines, IL-8 and nitric oxide by HMGB1

DNA and Cell Biology

Volumn 33, Issue 8, 2014, Pages 550-565

  Amin, Ashok R ^a,b   Islam, Abul B M M K ^c  

^a EDWARD VIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^b NYU HOSPITAL FOR JOINT DISEASES   (United States)

^c UNIVERSITY OF DHAKA   (Bangladesh)

Author keywords

[No Author keywords available]

Indexed keywords

CALVASCULIN; CCL3L1 CHEMOKINE; CCL4L1 CHEMOKINE; CCL4L2 CHEMOKINE; CHEMOKINE; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; CXCL3 CHEMOKINE; GRANULOCYTE CHEMOTACTIC PROTEIN 2; HIGH MOBILITY GROUP B PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; HIGH MOBILITY GROUP PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN 2; INTERLEUKIN 1BETA; INTERLEUKIN 8; LYMPHOID ENHANCER FACTOR 1; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; NITRIC OXIDE; PROTEIN S100A; PROTEIN S100A10; PROTEIN S100A11; RANTES; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; BIOINFORMATICS; CARTILAGE CELL; CELL NUCLEUS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOSOL; EX VIVO STUDY; EXTRACELLULAR SPACE; GENE EXPRESSION; GENOMICS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION;

CARTILAGE; CELLS, CULTURED; CHEMOKINES; CHONDROCYTES; FEMALE; GENE EXPRESSION REGULATION; GENOME, HUMAN; HMGB1 PROTEIN; HUMANS; INTERLEUKIN-8; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; OSTEOARTHRITIS; PARACRINE COMMUNICATION; S100 PROTEINS; TRANSCRIPTOME; UP-REGULATION;

EID: 84905255296     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2013.2198     Document Type: Article

References (106)

1. Abramson, S.B., Amin, A.R., Clancy, R.M., and Attur, M. (2001a). The role of nitric oxide in tissue destruction. Best practice & research. Clin Rheumatol 15, 831-845.
2. Abramson, S.B., Attur, M., Amin, A.R., and Clancy, R. (2001b). Nitric oxide and inflammatory mediators in the perpetuation of osteoarthritis. Curr Rheumatol Rep 3, 535-541.
3. Adjaye, J., Huntriss, J., Herwig, R., BenKahla, A., Brink, T.C., Wierling, C., Hultschig, C., Groth, D., Yaspo, M.L., Picton, H.M., Gosden, R.G., and Lehrach, H. (2005). Primary differentiation in the human blastocyst: comparative molecular portraits of inner cell mass and trophectoderm cells. Stem Cells 23, 1514-1525.
4. Alaaeddine, N., Olee, T., Hashimoto, S., Creighton-Achermann, L., and Lotz, M. (2001). Production of the chemokine RANTES by articular chondrocytes and role in cartilage degradation. Arthritis Rheum 44, 1633-1643.
5. Allen, S.J., Crown, S.E., and Handel, T.M. (2007). Chemokine: receptor structure, interactions, and antagonism. Ann Rev Immunol 25, 787-820.
6. Amin, A.R., and Abramson, S.B. (1998). The role of nitric oxide in articular cartilage breakdown in osteoarthritis. Curr Opin Rheumatol 10, 263-268.
7. Amin, A.R., Attur, M., and Abramson, S.B. (1999). Nitric oxide synthase and cyclooxygenases: distribution, regulation, and intervention in arthritis. Curr Opin Rheumatol 11, 202-209.
8. Amin, A.R., Attur, M., Patel, R.N., Thakker, G.D., Marshall, P.J., Rediske, J., Stuchin, S.A., Patel, I.R., and Abramson, S.B. (1997). Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage. Influence of nitric oxide. J Clin Invest 99, 1231-1237.
9. Amin, A.R., Attur, M.G., Thakker, G.D., Patel, P.D., Vyas, P.R., Patel, R.N., Patel, I.R., and Abramson, S.B. (1996). A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. Proc Natl Acad Sci U S A 93, 14014-14019.
10. Amin, A.R., Thompson, S., and Amin, S. (2007). Future of Genomics in Diagnosis of Human Arthritis: the hype, hope and metamorphosis for tomorrow. Future Med 2, 4-7.
11. Andersson, U., and Harris, E. (2004). HMGB1 is a potent trigger of arthritis. J Intern Med 255, 344-350.
12. Attur, M.G., Dave, M., Akamatsu, M., Katoh, M., and Amin, A.R. (2002a). Osteoarthritis or osteoarthrosis: the definition of inflammation becomes a semantic issue in the genomic era of molecular medicine. Osteoarthritis Cartilage 10, 1-4.
13. Attur, M.G., Dave, M., Cipolletta, C., Kang, P., Goldring, M.B., Patel, I.R., Abramson, S.B., and Amin, A.R. (2000). Reversal of autocrine and paracrine effects of interleukin 1 (IL-1) in human arthritis by type II IL-1 decoy receptor. Potential for pharmacological intervention. J Biol Chem 275, 40307-40315.
14. Attur, M.G., Dave, M.N., Leung, M.Y., Cipolletta, C., Meseck, M., Woo, S.L., and Amin, A.R. (2002b). Functional genomic analysis of type II IL-1beta decoy receptor: potential for gene therapy in human arthritis and inflammation. J Immunol 168, 2001-2010.
15. Attur, M.G., Dave, M.N., Stuchin, S., Kowalski, A.J., Steiner, G., Abramson, S.B., Denhardt, D.T., and Amin, A.R. (2001). Osteopontin: an intrinsic inhibitor of inflammation in cartilage. Arthritis Rheum 44, 578-584.
16. Attur, M.G., Dave, M.N., Tsunoyama, K., Akamatsu, M., Kobori, M., Miki, J., Abramson, S.B., Katoh, M., and Amin, A.R. (2002c). "A system biology" approach to bioinformatics and functional genomics in complex human diseases: arthritis. Curr Issues Mol Biol 4, 129-146.
17. Attur, M.G., Palmer, G.D., Al-Mussawir, H.E., Dave, M., Teixeira, C.C., Rifkin, D.B., Appleton, C.T., Beier, F., and Abramson, S.B. (2009). F-spondin, a neuroregulatory protein, is up-regulated in osteoarthritis and regulates cartilage metabolism via TGF-beta activation. FASEB J 23, 79-89.
18. Attur, M.G., Patel, I.R., Patel, R.N., Abramson, S.B., and Amin, A.R. (1998). Autocrine production of IL-1 beta by human osteoarthritis-affected cartilage and differential regulation of endogenous nitric oxide, IL-6, prostaglandin E2, and IL-8. Proc Assoc Am Phys 110, 65-72.
19. Bian, L. (2011). The role of S100A4 protein as a regulator of inflammation and bone metabolism in experimental arthritis. PhD thesis. Dept of Rheumatology and Inflammtion Research. The Sahlgtrenska Academy. University of Gothenburg. Gothenburg. Sweden.
20. Borzi, R.M., Mazzetti, I., Magagnoli, G., Paoletti, S., Uguccioni, M., Gatti, R., Orlandini, G., Cattini, L., and Facchini, A. (2002). Growth-related oncogene alpha induction of apoptosis in osteoarthritis chondrocytes. Arthritis Rheum 46, 3201-3211.
21. Borzi, R.M., Mazzetti, I., Marcu, K.B., and Facchini, A. (2004). Chemokines in cartilage degradation. Clin Orthop Relat Res, 427, S53-S61.
22. Bustin, M. (2010). High mobility group proteins. Biochim Biophys Acta 1799, 1-2.
23. Carlevaro, M.F., Cermelli, S., Cancedda, R., and Cancedda, F. (2000). Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation. J Cell Sci 113, 59-69.
24. Cecil, D.L., Johnson, K., Rediske, J., Lotz, M., Schmidt, A.M., and Terkeltaub, R. (2005). Inflammation-induced chondrocyte hypertrophy is driven by receptor for advanced glycation end products. J Immunol 175, 8296-8302.
25. Cecil, D.L, and Terkeltaub, R. (2008). Transamidation by transglutaminase 2 transforms S100A calgranulin into a procatabolic cytokine for chondrocytes J Immunol 180, 8378-8385.
26. Chen, G.Y., and Nuñez, G. (2010). Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol 10, 826-837.
27. Cristino, S., Piacentini, A., Manferdini, C., Codeluppi, K., Grassi, F., Facchini, A., and Lisignoli, G. (2008). Expression of CXC chemokines and their receptors is modulated during chondrogenic differentiation of human mesenchymal stem cells grown in three-dimensional scaffold: evidence in native cartilage. Tissue Eng Part A 14, 97-105.
28. Cuddapah, S., Schones, D.E., Cui, K., Roh, T.Y., Barski, A., Wei, G., Rochman, M., Bustin, M., and Zhao, K. (2011). Genomic profiling of HMGN1 reveals an association with chromatin at regulatory regions. Mol Cell Biol 31, 700-709.
29. Dave, M., and Amin, A.R. (2013). Yin-Yang regulation of prostaglandins and nitric oxide by PGD2 in human arthritis: reversal by celecoxib. Immunol Lett 152, 47-54.
30. De Ceuninck, F., Marcheteau, E., Berger, S., Caliez, A., Dumont, V., Raes, M., Anract, P., Leclerc, G., Boutin, J.A., and Ferry, G. (2005). Assessment of some tools for the characterization of the human osteoarthritic cartilage proteome. J Biomol Tech 16, 256-265.
31. De Jonge, H.J., Fehrmann, R.S., de Bont, E.S., Hofstra, R.M., Gerbens, F., Kamps, W.A., de Vries, E.G., van der Zee, A.G., te Meerman, and G.J., ter Elst, A., (2007). Evidence based selection of housekeeping genes. PloS One 2, e898.
32. Diener, K.R., Dasooqi, N.A., Lousberg, E.L., Hayball, J.D. (2013). Immunology and Cell Biology 91, 443-450.
33. Ellman, M.B., Yan, D., Ahmadinia, K., Chen, D., An, H.S, and Im, H.J., (2013). Fibroblast growth factor control of cartilage homeostasis. J Cell Biochem 114, 735-742.
34. Endres, M., Andreas, K., Kalwitz, G., Freymann, U., Neumann, K., Ringe, J., Sittinger, M., Haupl, T., and Kaps, C., (2010). Chemokine profile of synovial fluid from normal, osteoarthritis and rheumatoid arthritis patients: CCL25, CXCL10 and XCL1 recruit human subchondral mesenchymal progenitor cells. Osteoarthritis Cartilage 18, 1458-1466.
35. Erlandsson, M.C., Svensson, M.D., Jonsson, I.M., Bian, L., Ambartsumian, N., Andersson, S., Peng, Z., Vaaraniemi, J., Ohlsson, C., Andersson, K.M., and Bokarewa, M.I. (2013). Expression of metastasin S100A4 is essential for bone resorption and regulates osteoclast function. Biochim Biophys Acta 1833, 2653-2663.
36. García-Arnandis, I., Guillén, M.I., Gomar, F., Pelletier, J.P., Martel-Pelletier, J.M., and Alcaraz, M.J. (2001). High mobility group box 1 potentiates the pro-inflammatory effects of interleukin-1β in osteoarthritic synoviocytes. Arthritis Rheum 44, 1555-1567.
37. Ge, G., Seo, N.S., Liang, X., Hopkins, D.R., Höök, M., and Greenspan, D.S. (2004). Bone morphogenetic protein-1/tolloid-related metalloproteinases process osteoglycin and enhance its ability to regulate collagen fibrillogenesis. J Biol Chem 279, 41626-41633.
38. Goldstein, R.S., Bruchfeld, A., Yang, L., Qureshi, A.R., Gallowitsch-Puerta, M., Patel, N.B., Huston, B.J., Chavan, S., Rosas-Ballina, M., Gregersen, P.K., Czura, C.J., Sloan, R.P., Sama, A.E., and Tracey, K.J. (2007). Cholinergic antiinflammatory pathway activity and High Mobility Group Box-1 (HMGB1) serum levels in patients with rheumatoid arthritis. Mol Med 13, 210-215.
39. Grassi, F., Piacentini, A., Cristino, S., Toneguzzi, S., Cavallo, C., Facchini, A., and Lisignoli, G. (2003). Human osteoclasts express different CXC chemokines depending on cell culture substrate: molecular and immunocytochemical evidence of high levels of CXCL10 and CXCL12. Histochem Cell Biol 120, 391-400.
40. Hans-Peter, G., Thiennu, H., Ryan, A.M., Kowalski, J., Werb, Z., and Ferrara, N. (1999). EGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5, 623-628.
41. Haringman, J.J., Ludikhuize, J., and Tak, P.P. (2004). Chemokines in joint disease: the key to inflammation? Ann Rheum Dis 63, 1186-1194.
42. Harris, H.E., Andersson, U., and Pisetsky, D.S. (2012). HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease. Nat Rev Rheumatol 8, 195-202.
43. Haseeb, A., and Haqqi, T.M. (2013). Immunopathogenesis of osteoarthritis. Clin Immunol 146, 185-196.
44. Hayden, M.S, and Ghosh, S. (2012). NF-κB, the first quartercentury: remarkable progress and outstanding questions. Genes Dev 26, 203-234.
45. Heinola, T., Kouri, V.P., Clarijs, P., Ciferska, H., Sukura, A, Salo, J., and Konttinen YT. 2010. High mobility group box-1 (HMGB-1) in osteoarthritic cartilage. Clin Exp Rheumatol 28, 511-518.
46. Ikeda, T., Kawaguchi, H., Kamekura, S., Ogata, N., Mori, Y., Nakamura, K., Ikegawa, S., and Chung, U. (2005). Distinct roles of Sox5, Sox6, and Sox9 in different stages of chondrogenic differentiation. Bone Miner Metab 23, 237-240.
47. Janko, C., Filipović, M., Munoz, L.E., Schorn, C., Schett, G., Ivanović-Burmazović, I., and Herrmann, M. (2014). Redox Modulation of HMGB1-Related Signaling. Antioxid Redox Signal 20, 1075-1085.
48. Jin, D., Wu, Y., Zhao, L., Guo, J., Zhang, K., and Chen, Z. (2012). Atorvastatin reduces serum HMGB1 levels in patients with hyperlipidemia. Exp Ther Med 4, 1124-1126.
49. Johnson, K.A., van Etten, D., Nanda, N., Graham, R.M., and Terkeltaub, R.A. (2003). Distinct transglutaminase 2- independent and transglutaminase 2-dependent pathways mediate articular chondrocyte hypertrophy. J Biol Chem 278, 18824-18832.
50. Kang, R., Tang, D., Schapiro, N.E., Loux, T., Livesey, K.M., Billiar, T.R., Wang, H., Van Houten, B., Lotze, M.T., and Zeh, H.J. (2013). The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergetics. Oncogene 33, 567-577.
51. Kew, R.R., Penzo, M., Habiel, D.M., and Marcu, K.B. (2012). The IKKα-dependent NF-κB p52/RelB noncanonical pathway is essential to sustain a CXCL12 autocrine loop in cells migrating in response to HMGB1. J Immunol 188, 2380-2386.
52. Kim, H.A., Lee, Y.J., Seong, S.C., Choe, K.W., and Song, W. (2000). Apoptotic chondrocyte death in human osteoarthritis. J Rheumatol 27, 455-462.
53. Klune, J.R., Dhupar, R., Cardinal, J., Billiar, T.R., and Tsung, A. (2008). HMGB1: Endogenous danger signaling. Mol Med 14, 476-484.
54. Kokkola, R., Sundberg, E., Ulfgren, A.K., Palmblad, K., Li, J., Wang, H., Ulloa, L., Yang, H., Yan, X.J., Furie, R., Chiorazzi, N., Tracey, K.J., Andersson, U., and Harris, H.E. (2002). High mobility group box chromosomal protein 1: A novel proinflammatory mediator in synovitis. Arthritis Rheum 46, 2598-2603.
55. Kyostio-Moore, S., Nambiar, B., Hutto, E., Ewing, P.J., Piraino, S., Berthelette, P., Sookdeo, C., Matthews, G., and Armentano, D. (2011). STR/ort mice, a model for spontaneous osteoarthritis, exhibit elevated levels of both local and systemic inflammatory markers. Comp Med 61, 346-355.
56. Kyriakides, T.R., Jessica, W.Y., and Bornstein, P. (1999). Wound Healing in Mice with a disruption of the Thrombospondin 2 Gene. J Invest Dermatol 113, 782-787.
57. Lamore, S.D., Cabello, C.M., and Wondrak, G.T. (2010). HMGB1-directed drug discovery targeting cutaneous inflammatory dysregulation. Curr Drug Metab 11, 250-265.
58. Li, G., Liang, X., and Lotze, M.T. (2013). HMGB1: the central cytokine for all lymphoid cells. Front Immunol 4, 68-75.
59. Li, J., Wang, H., Mason, J.M., Levine, J., Yu, M., Ulloa, L., Czura, C.J., Tracey, K.J., and Yang, H. (2004). Recombinant HMGB1 with cytokine-stimulating activity. J Immunol Methods 289, 211-223.
60. Lisignoli, G., Manferdini, C., Codeluppi, K., Piacentini, A., Grassi, F., Cattini, L., Filardo, G., and Facchini, A. (2009). CCL20/CCR6 chemokine/receptor expression in bone tissue from osteoarthritis and rheumatoid arthritis patients: different response of osteoblasts in the two groups. J Cell Physiol 221, 154-160.
61. Lisignoli, G., Piacentini, A., Cristino, S., Grassi, F., Cavallo, C., Cattini, L., Tonnarelli, B., Manferdini, C., and Facchini, A. (2007). CCL20 chemokine induces both osteoblast proliferation and osteoclast differentiation: Increased levels of CCL20 are expressed in subchondral bone tissue of rheumatoid arthritis patients. J Cell Physiol 210, 798-806.
62. Liu-Bryan, R., and Terkeltaub, R. (2010). Chondrocyte innate immune myeloid differentiation factor 88-dependent signaling drives procatabolic effects of the endogenous Toll-like receptor 2/Toll-like receptor 4 ligands low molecular weight hyaluronan and high mobility group box chromosomal protein 1 in mice. Arthritis Rheum 62, 2004-2012.
63. Loeser, R.F., Yammani, R.R., Carlson, C.S., Chen, H., Cole, A., Im, H.J., Bursch, L.S., and Yan, S.D. (2005). Arthritis Rheum 52, 2376-2385.
64. Lotz, M., Terkeltaub, R., and Villiger, P.M. (1992). Cartilage and joint inflammation. Regulation of IL-8 expression by human articular chondrocytes. J Immunol 148, 466-473.
65. Merz, D., Liu, R., Johnson, K., and Terkeltaub, R. (2003). IL-8/CXCL8 and growth-related oncogene alpha/CXCL1 induce chondrocyte hypertrophic differentiation. J Immunol 171, 4406-4415.
66. Muller, S., Scaffidi, P., Degryse, B., Bonaldi, T., Ronfani, L., Agresti, A., Beltrame, M., and Bianchi, M.E. (2001). New EMBO members' review: the double life of HMGB1 chromatin protein: architectural factor and extracellular signal. EMBO J 20, 4337-4340.
67. Murata, M., Yudoh, K., and Masuko, K. (2008). The potential role of vascular endothelial growth factor (VEGF) in cartilage: how the angiogenic factor could be involved in the pathogenesis of osteoarthritis? Osteoarthritis Cartilage 16, 279-286.
68. O'Connell, P.A., Surette, A.P., Liwski, R.S., Svenningsson, P., and Waisman, D.M. (2010). S100A10 regulates plasminogendependent macrophage invasion. Blood 116, 1136-1146.
69. Palmblad, K., Sundberg, E., Diez, M., Soderling, R., Aveberger, A.C., Andersson, U., and Harris, H.E. (2007). Morphological characterization of intra-articular HMGB1 expression during the course of collagen-induced arthritis. Arthritis Res Ther 9, R35.
70. Palmer, G.D., Piton, A.H., Thant, L.M., Oliveira, S.M., D'Angelo, M., Attur, M.G., Abramson, S.B., and Teixeira, C.C. (2010). F-spondin (Spondin 1) regulates chondrocyte terminal differentiation and endochondral bone formation. J Orthop Res 28, 1323-1329.
71. Patel, I.R., Attur, M.G., Patel, R.N., Stuchin, S.A., Abagyan, R.A., Abramson, S.B., and Amin, A.R. (1998). TNF-alpha convertase enzyme from human arthritis-affected cartilage: isolation of cDNA by differential display, expression of the active enzyme, and regulation of TNF-alpha. J Immunol 160, 4570-4579.
72. Pelletier, J.P., Martel-Pelletier, J., and Abramson, S.B. (2001). Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum 44, 1237-1247.
73. Perez-Llamas, C., and Lopez-Bigas, N. (2011). Gitools: analysis and visualisation of genomic data using interactive heatmaps. PloS One 6, e19541.
74. Pritzker, K.P., Gay, S., Jimenez, S.A., Ostergaard, K., Pelletier, J.P., Revell, P.A., Salter, D., and van den Berg, W.B. (2006). Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage 14, 13-29.
75. Pullerits, R., Jonsson, I.M., Kollias, G., and Tarkowski, A. (2008). Induction of arthritis by high mobility group box chromosomal protein 1 is independent of tumor necrosis factor signaling. Arthritis Res Ther 10, R72.
76. Pullerits, R., Jonsson, I.M., Verdrengh, M., Bokarewa, M., Andersson, U., Erlandsson-Harris H., and Tarkowski, A. (2003). High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritis. Arthritis Rheum 48, 1693-1700.
77. Pulsatelli, L., Addimanda, O., Brusi, V., Pavloska, B., and Meliconi, R. (2013). New findings in osteoarthritis pathogenesis: therapeutic implications. Ther Adv Chronic Dis 4, 23-43.
78. Pulsatelli, L., Dolzani, P., Piacentini, A., Silvestri, T., Ruggeri, R., Gualtieri, G., Meliconi, R., and Facchini, A. (1999). Chemokine production by human chondrocytes. J Rheumatol 26, 1992-2001.
79. Rao, J., Elliott, M.R., Leitinger, N., Jensen, R.V., Goldberg, J.B., and Amin, A.R. (2011). RahU: an inducible and functionally pleiotropic protein in Pseudomonas aeruginosa modulates innate immunity and inflammation in host cells. Cell Immunol 270, 103-113.
80. Schiraldi, M., Raucci, A., Munoz, L.M., Livoti, E., Celona, B., Venereau, E., Apuzzo, T., De Marchis, F., Pedotti, M., Bachi, A., Thelen, M., Varani, L., Mellado, M., Proudfoot, A., Bianchi, M.E., and Uguccioni, M. (2012). HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4. J Exp Med 209, 551-563.
81. Seol, D., McCabe, D.J., Choe, H., Zheng, H., Yu, Y., Jang, K., Walter, M.W., Lehman, A.D., Ding, L., Buckwalter, J.A., and Martin, J.A. (2012). Chondrogenic progenitor cells respond to cartilage injury. Arthritis Rheum 64, 3626-3637.
82. Sims, G.P., Rowe, D.C., Rietdijk, S.T., Herbst, R., and Coyle, A.J. (2010). HMGB1 and RAGE in inflammation and cancer. Ann Rev Immunol 28, 367-388.
83. Smyth, G.K. (2004). Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3, Article3.
84. Song, C., Zhou, X., Dong, Q., Fan, R., Wu, G., Ji, B., Meng, Q., and Zheng, M. (2012). Regulation of inflammatory response in human chondrocytes by lentiviral mediated RNA interference against S100A10. Inflamm Res 61, 1219-1227.
85. Sparvero, L.J., Asafu-Adjei, D., Kang, R., Tang, D., Amin, N., Im, J., Rutledge, R., Lin, B., Amoscato, A.A., Zeh, H.J., and Lotze, M.T. (2009). RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation. J Transl Med 7, 17.
86. Tanaka, K., Matsumoto, E., Higashimaki, Y., Katagiri, T., Sugimoto, T., Seino, S., and Kaji, H. (2012). Role of osteoglycin in the linkage between muscle and bone. J Biol Chem 287, 11616-11628.
87. Tang, D., Billiar, T.R., and Lotze, M.T. (2012). A Janus tale of two active high mobility group box 1 (HMGB1) redox states. Mol Med 18, 1360-1362.
88. Taniguchi, N., Carames, B., Hsu, E., Cherqui, S., Kawakami, Y., and Lotz, M. (2011). Expression patterns and function of chromatin protein HMGB2 during mesenchymal stem cell differentiation. J Biol Chem 286, 41489-41498.
89. Taniguchi, N., Carames, B., Ronfani, L., Ulmer, U., Komiya, S., Bianchi, M.E., and Lotz, M. (2009). Aging-related loss of the chromatin protein HMGB2 in articular cartilage is linked to reduced cellularity and osteoarthritis. Proc Natl Acad Sci U S A 106, 1181-1186.
90. Taniguchi, N., Yoshida, K., Ito, T., Tsuda, M., Mishima, Y., Furumatsu, T., Ronfani, L., Abeyama, K., Kawahara, K., Komiya, S., Maruyama, I., Lotz, M., Bianchi, M.E., and Asahara, H. (2007). Stage-specific secretion of HMGB1 in cartilage regulates endochondral ossification. Mol Cell Biol 27, 5650-5663.
91. Tasheva, E.S., Koester, A., Paulsen, A.Q., Garrett, A.S., Boyle, D.L., Davidson, H.J., Song, M., Fox, N., and Conrad, G.W. (2002). Mimecan/osteoglycin-deficient mice have collagen fibril abnormalities. Mol Vis 31, 407-415.
92. Taylor, D.K., Meganck, J.A., Terkhorn, S., Rajani, R., Naik, A., O'Keefe, R.J., Goldstein, S.A., and Hankenson, K.D. (2009). Thrombospondin-2 influences the proportion of cartilage and bone during fracture healing. J Bone Miner Res 24, 1043-1054.
93. Urbonaviciute, V., Meister, S., Fürnrohr, B.G., Frey, B., Gückel, E., Schett, G., Herrmann, M., and Voll., R.E. (2009). Oxidation of the alarmin high-mobility group box 1 protein (HMGB1) during apoptosis. Autoimmunity 42, 305-307.
94. Van Lent, P.L., Grevers, L.C., Blom, A.B., Arntz, O.J., van de Loo, F.A., van der Kraan, P., Abdollahi-Roodsaz, S., Srikrishna, G., Freeze, H., Sloetjes, A., Nacken, W., Vogl, T., Roth, J, and van den Berg, WB. (2008). Stimulation of chondrocytemediated cartilage destruction by S100A8 in experimental murine arthritis. Arthritis Rheum 58, 3776-3787.
95. Velegraki, M., Koutala, H., Tsatsanis, C., and Papadaki, H.A. (2012). Increased levels of the high mobility group box 1 protein sustain the inflammatory bone marrow microenvironment in patients with chronic idiopathic neutropenia via activation of toll-like receptor 4. J Clin Immunol 32, 312-322.
96. Venereau, E., Casalgrandi, M., Schiraldi, M., Antoine, D.J., Cattaneo, A., De Marchis, F., Liu, J., Antonelli, A., Preti, A., Raeli, L., Shams, S.S., Yang, H., Varani, L., Andersson, U., Tracey K.J., Bachi, A., Uguccioni, M., and Bianchi, M.E. (2012). Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release. J Exp Med 209, 1519-1528.
97. Wahamaa, H., Vallerskog, T., Qin, S., Lunderius, C., LaRosa, G., Andersson, U., and Harris, H.E. (2007). HMGB1-secreting capacity of multiple cell lineages revealed by a novel HMGB1 ELISPOT assay. J Leukoc Biol 81, 129-136.
98. Wang, G., Yan, Q., Woods, A., Aubrey, L.A., Feng, Q., and Beier, F. (2011). Inducible nitric oxide synthase-nitric oxide signaling mediates the mitogenic activity of Rac1 during endochondral bone growth. J Cell Sci 124, 3405-3413.
99. Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J.M., Ombrellino, M., Che, J., Frazier, A., Yang, H., Ivanova, S., Borovikova, L., Manogue, K.R., Faist, E., Abraham, E., Andersson, J., Andersson, U., Molina, P.E., Abumrad, N.N., Sama, A., and Tracey, K.J. (1999). HMG-1 as a later mediator of endotoxin lethality in mice. Science 285, 248-251.
100. Yammani, R.R. (2012). S100 proteins in cartilage: role in arthritis. Biochim Biophys Acta 1822, 600-606.
101. Yang, D., Tewary, P., de la Rosa, G., Wei, F., and Oppenheim, J.J. (2010). The alarmin functions of high-mobility group proteins. Biochim Biophys Acta 1799, 157-163.
102. Yang, H., Lundbäck, P., Ottosson, L., Erlandsson-Harris, H., Venereau, E., Bianchi, M.E., Al-Abed, Y., Andersson, U., Tracey, K.J., and Antoine, D.J. (2012). Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1). Mol Med 18, 250-259.
103. Yang, H., and Tracey, K.J. (2005). High mobility group box 1 (HMGB1). Crit Care Med 33, S472-S474.
104. Yang, H., Wang, H., Czura, C.J., and Tracey, K.J. (2005). The cytokine activity of HMGB1. J Leukoc Biol 78, 1-8.
105. Zhang, X., Wang, H., and Wang, J. (2013). Expression of HMGB1 and NF-κB p65 and its significance in non-small cell lung cancer. Contemp Oncol (Pozn) 17, 350-355.
106. Zhou, P.H., Liu, S.Q., and Peng, H. (2008). The effect of hyaluronic acid on IL-1beta-induced chondrocyte apoptosis in a rat model of osteoarthritis. J Orthop Res 26, 1643-1648.